Personnel
Dr. David U'Prichard joins CoGenesys board of directors
Published in Gene Therapy Weekly, January 18th, 2007
"David U'Prichard has an acclaimed background in supporting and advancing innovative R&D programs within both life sciences companies and Big Pharma," stated Steven C. Mayer, chief executive officer of CoGenesys. "We are honored that David has joined our board. With his election, we have now completed the composition of the board, bringing to seven the number of directors."
U'Prichard commented, "CoGenesys has a strong heritage and broad platform for developing breakthrough products that can address real patient needs. I have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-01-18)
More Articles from Gene Therapy Weekly
- Gene Research
Genetic defect in protein found to be cause of a form of brittle bone disease - Angiogenesis
New findings from Oita University, Department of Neurosurgery in the area of angiogenesis described - Asthma Gene Therapy
Research from National Taiwan University, Institute of Immunology broadens understanding of asthma gene therapy - Cancer Gene Therapy
Data from University of South Alabama, Cancer Institute provide new insights into cancer gene therapy - Cancer Gene Therapy
Investigators at Hospital, Department of Surgery target cancer gene therapy - Cancer Gene Therapy
Investigators at Sungkyunkwan University, Cancer Center target cancer gene therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
